Radboud University Medical Center and Philips Sign 10-Year Patient Monitoring Partnership and Agreement to Keep Software State-of-the-Art

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring applications. All Radboudumc departments will have access to Philips' patient monitoring portfolio. In addition, the two parties have signed a service agreement, to continuously deliver clinical and technical services to maintain the monitors and underlying IT platform. New software developments for bedside or central station monitors are frequent, as are necessary clinical software and security updates. With this agreement, Radboudumc will always have access to the latest updates, software, and security for their patient monitoring systems.

The goal of Radboudumc is to create a reliable and scalable patient monitoring ecosystem that offers flexibility in the future. This collaboration could help us to reduce alarms and allow data to be accessed and clinical decisions to be made from anywhere, helping to optimize patient monitoring and clinical outcomes. The ecosystem and platform that Philips offers create new possibilities and opportunities.

While patients are continuously monitored in operating rooms, Intensive Care Units and other departments with bedside patient monitors, monitoring also can happen during patient transit. Some interchangeable monitors can be used during patient transport to ensure no patient data is lost. The data is stored in the software and IT systems behind the monitors, which support caregivers in the interpretation of all this data, using algorithms, for example, to provide the best possible insight into the patient's health status and signal a deterioration in the patient.

"Patient monitoring is an innovation focus of Philips, and we use our technology to support healthcare providers to better care for their patients. The hardware, the monitors, and sensors are the visible parts of the monitoring system, but the invisible part - the software - is where we can make a big difference for healthcare providers. By bringing together patient data and distilling information from it, these systems and software can support caregivers in taking better care of patients and intervening more quickly when needed. In the future, we will see many developments in this area including the introduction of artificial intelligence," said Léon Kempeneers, Managing Director of Philips Benelux.

Philips is also focusing on innovations to enhance the usability of monitors. A few recent examples are the developments of alarm sounds to reduce alarm fatigue and create environments that promote patient recovery. In addition, Philips recently introduced the Visual Patient Avatar that aggregates patient data from the monitor, during surgery, into a "virtual patient" on the monitor screen to help caregivers interpret data more easily.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...